We are pleased to announce the next round of Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) KL2 awards with this call for new applications. Full applications will be due on August 5, 2024, with an anticipated appointment date in October 2024. 

During its first fourteen years, the GHUCCTS has been privileged to award KL2 support to 26 junior faculty colleagues from Georgetown and Howard Universities and from MedStar Health, who have leveraged this opportunity in order to publish >500 peer-reviewed manuscripts, receive over 50 extramural grants and conduct 30 sponsored clinical trials. 

This K-series career development award is nearly identical to our previous KL2 awards and analogous to individual K23, K08, or K01 awards, with a focus on developing early-career (MD or equivalent; doctorally-trained nurses, pharmacists or dentists; a n d clinically or translationally-oriented PhD) faculty investigators from any discipline and any of our eligible institutions through an inter or multi-disciplinary mentored translational research experience so that they can become independent, extramurally-funded investigators. Given the goals of the GHUCCTS, awards will favor those: 1) who propose novel trans-, inter-, or multi-disciplinary and collaborative/team research projects; 2) from any parts of the entire T1-T4 translational continuum; 3) which span departments, disciplines, and institutions; and, 4) address significant health disparities. 

For more details, including application instructions, visit our KL2 Scholars page or download the RFA announcement.